ETV5 and type 2 diabetes mellitus: The main findings in this study were that T2D patients under current glucose-lowering drugs compared with healthy control subjects have significant ROCK activation in their PBMCs as determined by increased phosphorylation of two ROCK direct targets (MYPT1 and ERM).